Responses
Clinical care/Education/Nutrition
Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial
Compose a Response to This Article
Other responses
No responses have been published for this article.